-
2
-
-
84923247523
-
Consensus guidelines for the detection of immunogenic cell death
-
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology (2014) 3(9):e955691. doi:10.4161/21624011.2014.955691.
-
(2014)
Oncoimmunology
, vol.3
, Issue.9
-
-
Kepp, O.1
Senovilla, L.2
Vitale, I.3
Vacchelli, E.4
Adjemian, S.5
Agostinis, P.6
-
3
-
-
84921418427
-
Classification of current anticancer immunotherapies
-
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buque A, Senovilla L, Baracco EE, et al. Classification of current anticancer immunotherapies. Oncotarget (2014) 5(24):12472-508. doi:10.18632/oncotarget.2998.
-
(2014)
Oncotarget
, vol.5
, Issue.24
, pp. 12472-12508
-
-
Galluzzi, L.1
Vacchelli, E.2
Bravo-San Pedro, J.M.3
Buque, A.4
Senovilla, L.5
Baracco, E.E.6
-
4
-
-
79952280438
-
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
-
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev (2011) 30(1):61-9. doi:10.1007/s10555-011-9273-4.
-
(2011)
Cancer Metastasis Rev
, vol.30
, Issue.1
, pp. 61-69
-
-
Kepp, O.1
Galluzzi, L.2
Martins, I.3
Schlemmer, F.4
Adjemian, S.5
Michaud, M.6
-
5
-
-
84938215240
-
The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: from sensor to the plasma membrane and beyond
-
van Vliet AR, Martin S, Garg AD, Agostinis P. The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: from sensor to the plasma membrane and beyond. Semin Cancer Biol (2015) 33:74-85. doi:10.1016/j.semcancer.2015.03.010.
-
(2015)
Semin Cancer Biol
, vol.33
, pp. 74-85
-
-
van Vliet, A.R.1
Martin, S.2
Garg, A.D.3
Agostinis, P.4
-
6
-
-
84938324518
-
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
-
Adkins I, Fucikova J, Garg AD, Agostinis P, Spisek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology (2014) 3:e968434. doi:10.4161/21624011.2014.968434.
-
(2014)
Oncoimmunology
, vol.3
-
-
Adkins, I.1
Fucikova, J.2
Garg, A.D.3
Agostinis, P.4
Spisek, R.5
-
7
-
-
20344375444
-
The controversial abscopal effect
-
Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treat Rev (2005) 31(3):159-72. doi:10.1016/j.ctrv.2005.03.004.
-
(2005)
Cancer Treat Rev
, vol.31
, Issue.3
, pp. 159-172
-
-
Kaminski, J.M.1
Shinohara, E.2
Summers, J.B.3
Niermann, K.J.4
Morimoto, A.5
Brousal, J.6
-
8
-
-
84857954861
-
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
-
Ciampricotti M, Hau CS, Doornebal CW, Jonkers J, de Visser KE. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat Med (2012) 18(3):344-6. doi:10.1038/nm.2652.
-
(2012)
Nat Med
, vol.18
, Issue.3
, pp. 344-346
-
-
Ciampricotti, M.1
Hau, C.S.2
Doornebal, C.W.3
Jonkers, J.4
de Visser, K.E.5
-
9
-
-
84911453574
-
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
-
Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology (2014) 3(7):e944047. doi:10.4161/21624011.2014.944047.
-
(2014)
Oncoimmunology
, vol.3
, Issue.7
-
-
Michaud, M.1
Xie, X.2
Bravo-San Pedro, J.M.3
Zitvogel, L.4
White, E.5
Kroemer, G.6
-
10
-
-
84918574716
-
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
-
Koks CA, Garg AD, Ehrhardt M, Riva M, Vandenberk L, Boon L, et al. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death. Int J Cancer (2015) 136(5):E313-25. doi:10.1002/ijc.29202.
-
(2015)
Int J Cancer
, vol.136
, Issue.5
, pp. E313-E325
-
-
Koks, C.A.1
Garg, A.D.2
Ehrhardt, M.3
Riva, M.4
Vandenberk, L.5
Boon, L.6
-
11
-
-
84959386808
-
Irradiation of necrotic cancer cells employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
-
Vandenberk L, Garg AD, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology (2016) 5(2):e1083669. doi:10.1080/2162402X.2015.1083669.
-
(2016)
Oncoimmunology
, vol.5
, Issue.2
-
-
Vandenberk, L.1
Garg, A.D.2
Verschuere, T.3
Koks, C.4
Belmans, J.5
Beullens, M.6
-
12
-
-
84959452716
-
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
-
Garg AD, Vandenberk L, Koks C, Verschuere T, Boon L, Van Gool S, et al. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma. Sci Transl Med (2016) 8(328):328ra27. doi:10.1126/scitranslmed.aae0105.
-
(2016)
Sci Transl Med
, vol.8
, Issue.328
-
-
Garg, A.D.1
Vandenberk, L.2
Koks, C.3
Verschuere, T.4
Boon, L.5
Van Gool, S.6
-
13
-
-
84959387168
-
Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: a large-scale meta-analysis
-
Garg AD, De Ruysscher D, Agostinis P. Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: a large-scale meta-analysis. Oncoimmunology (2016) 5(2):e1069938. doi:10.1080/2162402X.2015.1069938.
-
(2016)
Oncoimmunology
, vol.5
, Issue.2
-
-
Garg, A.D.1
De Ruysscher, D.2
Agostinis, P.3
-
14
-
-
84938506616
-
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
-
Garg AD, Elsen S, Krysko DV, Vandenabeele P, de Witte P, Agostinis P. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. Oncotarget (2015) 6(29):26841-60. doi:10.18632/oncotarget.4754.
-
(2015)
Oncotarget
, vol.6
, Issue.29
, pp. 26841-26860
-
-
Garg, A.D.1
Elsen, S.2
Krysko, D.V.3
Vandenabeele, P.4
de Witte, P.5
Agostinis, P.6
-
15
-
-
34948820602
-
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
-
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13(9):1050-9. doi:10.1038/nm1622.
-
(2007)
Nat Med
, vol.13
, Issue.9
, pp. 1050-1059
-
-
Apetoh, L.1
Ghiringhelli, F.2
Tesniere, A.3
Obeid, M.4
Ortiz, C.5
Criollo, A.6
-
16
-
-
84913586780
-
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
-
Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med (2014) 20(11):1301-9. doi:10.1038/nm.3708.
-
(2014)
Nat Med
, vol.20
, Issue.11
, pp. 1301-1309
-
-
Sistigu, A.1
Yamazaki, T.2
Vacchelli, E.3
Chaba, K.4
Enot, D.P.5
Adam, J.6
-
17
-
-
84947763610
-
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
-
Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, et al. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science (2015) 350(6263):972-8. doi:10.1126/science.aad0779.
-
(2015)
Science
, vol.350
, Issue.6263
, pp. 972-978
-
-
Vacchelli, E.1
Ma, Y.2
Baracco, E.E.3
Sistigu, A.4
Enot, D.P.5
Pietrocola, F.6
-
18
-
-
33846057130
-
Calreticulin exposure dictates the immunogenicity of cancer cell death
-
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2007) 13(1):54-61. doi:10.1038/nm1523.
-
(2007)
Nat Med
, vol.13
, Issue.1
, pp. 54-61
-
-
Obeid, M.1
Tesniere, A.2
Ghiringhelli, F.3
Fimia, G.M.4
Apetoh, L.5
Perfettini, J.L.6
-
19
-
-
84857997683
-
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
-
Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J (2012) 31(5):1062-79. doi:10.1038/emboj.2011.497.
-
(2012)
EMBO J
, vol.31
, Issue.5
, pp. 1062-1079
-
-
Garg, A.D.1
Krysko, D.V.2
Verfaillie, T.3
Kaczmarek, A.4
Ferreira, G.B.5
Marysael, T.6
-
20
-
-
79952533264
-
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
-
Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene (2011) 30(10):1147-58. doi:10.1038/onc.2010.500.
-
(2011)
Oncogene
, vol.30
, Issue.10
, pp. 1147-1158
-
-
Martins, I.1
Kepp, O.2
Schlemmer, F.3
Adjemian, S.4
Tailler, M.5
Shen, S.6
-
21
-
-
84934317844
-
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
-
Dudek-Peric AM, Ferreira GB, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res (2015) 75(8):1603-14. doi:10.1158/0008-5472.CAN-14-2089.
-
(2015)
Cancer Res
, vol.75
, Issue.8
, pp. 1603-1614
-
-
Dudek-Peric, A.M.1
Ferreira, G.B.2
Muchowicz, A.3
Wouters, J.4
Prada, N.5
Martin, S.6
-
22
-
-
70449781226
-
Chemotherapy induces ATP release from tumor cells
-
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle (2009) 8(22):3723-8. doi:10.4161/cc.8.22.10026.
-
(2009)
Cell Cycle
, vol.8
, Issue.22
, pp. 3723-3728
-
-
Martins, I.1
Tesniere, A.2
Kepp, O.3
Michaud, M.4
Schlemmer, F.5
Senovilla, L.6
-
23
-
-
84923061042
-
Inhibition of HIF-1alpha by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
-
Zhao T, Ren H, Jia L, Chen J, Xin W, Yan F, et al. Inhibition of HIF-1alpha by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. Oncotarget (2015) 6(4):2250-62. doi:10.18632/oncotarget.2948.
-
(2015)
Oncotarget
, vol.6
, Issue.4
, pp. 2250-2262
-
-
Zhao, T.1
Ren, H.2
Jia, L.3
Chen, J.4
Xin, W.5
Yan, F.6
-
24
-
-
36348940608
-
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
-
Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol (2008) 89(Pt 1):1-47. doi:10.1099/vir.0.83391-0.
-
(2008)
J Gen Virol
, vol.89
, pp. 1-47
-
-
Randall, R.E.1
Goodbourn, S.2
-
25
-
-
78549275158
-
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
-
Zappasodi R, Pupa SM, Ghedini GC, Bongarzone I, Magni M, Cabras AD, et al. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death. Cancer Res (2010) 70(22):9062-72. doi:10.1158/0008-5472.CAN-10-1825.
-
(2010)
Cancer Res
, vol.70
, Issue.22
, pp. 9062-9072
-
-
Zappasodi, R.1
Pupa, S.M.2
Ghedini, G.C.3
Bongarzone, I.4
Magni, M.5
Cabras, A.D.6
-
26
-
-
79960406242
-
Human tumor cells killed by anthracyclines induce a tumor-specific immune response
-
Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, et al. Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res (2011) 71(14):4821-33. doi:10.1158/0008-5472.CAN-11-0950.
-
(2011)
Cancer Res
, vol.71
, Issue.14
, pp. 4821-4833
-
-
Fucikova, J.1
Kralikova, P.2
Fialova, A.3
Brtnicky, T.4
Rob, L.5
Bartunkova, J.6
-
27
-
-
84878767645
-
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells
-
Bugaut H, Bruchard M, Berger H, Derangere V, Odoul L, Euvrard R, et al. Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. PLoS One (2013) 8(6):e65181. doi:10.1371/journal.pone.0065181.
-
(2013)
PLoS One
, vol.8
, Issue.6
-
-
Bugaut, H.1
Bruchard, M.2
Berger, H.3
Derangere, V.4
Odoul, L.5
Euvrard, R.6
-
28
-
-
83755181759
-
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
-
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (2011) 334(6062):1573-7. doi:10.1126/science.1208347.
-
(2011)
Science
, vol.334
, Issue.6062
, pp. 1573-1577
-
-
Michaud, M.1
Martins, I.2
Sukkurwala, A.Q.3
Adjemian, S.4
Ma, Y.5
Pellegatti, P.6
-
29
-
-
84887445500
-
Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A
-
Garg AD, Dudek AM, Agostinis P. Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A. Cell Death Dis (2013) 4:e826. doi:10.1038/cddis.2013.372.
-
(2013)
Cell Death Dis
, vol.4
-
-
Garg, A.D.1
Dudek, A.M.2
Agostinis, P.3
-
30
-
-
84921747766
-
Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells
-
Martin S, Dudek-Peric AM, Maes H, Garg AD, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol (2015) 93(3):290-304. doi:10.1016/j.bcp.2014.12.003.
-
(2015)
Biochem Pharmacol
, vol.93
, Issue.3
, pp. 290-304
-
-
Martin, S.1
Dudek-Peric, A.M.2
Maes, H.3
Garg, A.D.4
Gabrysiak, M.5
Demirsoy, S.6
-
31
-
-
84879783969
-
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
-
Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy (2013) 9(9):1292-307. doi:10.4161/auto.25399.
-
(2013)
Autophagy
, vol.9
, Issue.9
, pp. 1292-1307
-
-
Garg, A.D.1
Dudek, A.M.2
Ferreira, G.B.3
Verfaillie, T.4
Vandenabeele, P.5
Krysko, D.V.6
-
32
-
-
84894527433
-
Immunological effects of chemotherapy in spontaneous breast cancers
-
Kroemer G, Galluzzi L, Zitvogel L. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology (2013) 2(12):e27158. doi:10.4161/onci.27158.
-
(2013)
Oncoimmunology
, vol.2
, Issue.12
-
-
Kroemer, G.1
Galluzzi, L.2
Zitvogel, L.3
-
33
-
-
84942551759
-
A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription
-
Musahl AS, Huang X, Rusakiewicz S, Ntini E, Marsico A, Kroemer G, et al. A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription. Oncogene (2015) 34(39):5046-54. doi:10.1038/onc.2014.424.
-
(2015)
Oncogene
, vol.34
, Issue.39
, pp. 5046-5054
-
-
Musahl, A.S.1
Huang, X.2
Rusakiewicz, S.3
Ntini, E.4
Marsico, A.5
Kroemer, G.6
-
34
-
-
84931373205
-
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
-
Stoll G, Bindea G, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget (2015) 6(14):11894-909. doi:10.18632/oncotarget.4180.
-
(2015)
Oncotarget
, vol.6
, Issue.14
, pp. 11894-11909
-
-
Stoll, G.1
Bindea, G.2
Mlecnik, B.3
Galon, J.4
Zitvogel, L.5
Kroemer, G.6
|